Charles River Laboratories (CRL) Common Stock USD0.01

Sell:$176.80Buy:$176.93$0.29 (0.16%)

Prices delayed by at least 15 minutes
Sell:$176.80
Buy:$176.93
Change:$0.29 (0.16%)
Deal now
Prices delayed by at least 15 minutes
Sell:$176.80
Buy:$176.93
Change:$0.29 (0.16%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Key people

James C. Foster
Chairman of the Board, President, Chief Executive Officer
Flavia H. Pease
Chief Financial Officer, Corporate Executive Vice President
Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Victoria L. Creamer
Corporate Executive Vice President, Chief People Officer
Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Martin W. Mackay
Lead Independent Director
Nancy C. Andrews
Independent Director
Steven K. Barg
Independent Director
Abraham N. Ceesay
Independent Director
Mark Joseph Enyedy
Independent Director
Click to see more

Key facts

  • EPIC
    CRL
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US1598641074
  • Market cap
    $8.25bn
  • Employees
    18,600
  • Shares in issue
    51.20m
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.